Authors
Michael T Okafor, Fredrick O Ugwumba, Solomon Kenechukwu Anyimba, Adaobi G Obiefuna, Queenet Chiamaka Onyebuchukwu, Osita Nwabugwu, George U Ali, Theresa Ukamaka Nwagha
Published in
Annals of African medicine. Nov 18, 2026. Epub Nov 18, 2026.
Abstract
Prostate cancer remains a major global health challenge, and the antiandrogen toxicities associated with its management heavily reduce patient quality of life. Immunotoxic lifestyle habits, such as an unhealthy diet, inadequate sleep, and insufficient exercise, are major drivers of T-cell-mediated immune dysfunction in immune-mediated inflammatory diseases (IMIDs) and cancers. Evidence demonstrates that lifestyle modification interventions acting as therapeutic adjuncts can reduce drug treatment requirements (DTRs), adverse effects, and organ toxicities in the management of IMIDs. While literature exists regarding how lifestyle modification may be used as a therapeutic adjunct for some IMIDs and cancers to reduce DTRs, adverse effects, and organ toxicities associated with their management drugs, there is currently none available for prostate cancer. Online searches were conducted across databases such as Google Scholar, PubMed, BioMed Central, and SciELO. Articles were reviewed using keywords such as prostate cancer, lifestyle modification, therapeutic adjuncts, and immune dysfunction. As adjunctive therapeutic strategies for prostate cancer care, lifestyle modification interventions could potentially reduce antiandrogen DTRs, costs, adverse effects, and organ toxicities.
PMID:
43049114
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0